QOL | malecare.org

Enzalutamide (Xtandi) Improves The Quality of Life As Well As Extending Life In Men With Castrate Resistant Prostate Cancer

In clinical trials Enzalutamide (Xtandi) significantly increased the overall survival and radiographic progression-free survival of men when compared with placebo. The trial, called PREVAIL evaluated men who were asymptomatic and minimally symptomatic, chemotherapy-naive with metastatic castration-resistant prostate cancer. The researchers expanded the data analysis and evaluated the effect of Xtandi on the men’s health-related quality [...]

By Malecare|2020-02-04T11:37:28-05:00June 12th, 2015|Advanced Prostate Cancer, enzalutamide, Uncategorized, Understanding APC, Xtandi|0 Comments

New ASCO/CCO Prostate Cancer Guidelines Emphasize Quality of Life

It is important that survivors keep up on the professional standards of our doctors to make sure that we receive the best care and the most current care. It is easy for doctors to just do it the way they were first trained, even if their training was twentyor thirty years ago. Recent news includes [...]

By Malecare|2017-10-19T10:47:59-04:00September 29th, 2014|Advanced Prostate Cancer, ASCO, CCO, How We Live, Politics of Cancer, Quality of Life, Uncategorized, Understanding APC|0 Comments

Understanding the Real Concerns Men with Advanced Prostate Cancer Have About the Quality of Their Life

Advanced prostate cancer and its treatments has significant impacts on a man’s quality of life (QOL) as well as their perception of their health. It is important to better understand these concerns, especially those currently not captured by the currently available health-related quality of life (HRQL) instruments. In the quest to better understand these concerns [...]

By Malecare|2020-02-04T10:15:32-05:00August 21st, 2014|Advanced Prostate Cancer, Research, survivorship, Uncategorized, Understanding APC|0 Comments

Denosumab is Superior to Zoledronic Acid (ZA) for Pain Interference and Quality of Life

Men with castration-resistant prostate cancer (CRPC) and bone metastases (BM) will eventually develop debilitating pain that impacts daily functioning and diminishes their quality of life. Based on prior studies, including a phase III trial, the superiority of denosumab over zoledronic acid (ZA) in delaying or preventing skeletal-related events (pathological fracture, radiation or surgery to the [...]

By Malecare|2020-02-04T10:22:05-05:00May 27th, 2014|Advanced Prostate Cancer, Bone Health, Bone Metastases, denosumab - Xgeva, Drugs & Treatments, Quality of Life, Uncategorized, Understanding APC, Zometa|0 Comments

Denosumab or Zoledronic Acid – Which is Superior for Pain Interference and Improving Quality of Life?

Men with castration-resistant prostate cancer (CRPC) and bone metastases (BM) will often have debilitating pain that impacts every aspect of their daily functioning thus significantly diminishing their quality of life (QoL). Finding the best drug or treatment to control the pain will allow men to have a more complete and fulfilling life as well as [...]

By Malecare|2014-04-24T12:38:13-04:00April 24th, 2014|Advanced Prostate Cancer, bisphosphonates, Bone Health, Bone Metastases, denosumab - Xgeva, Drugs & Treatments, Pain, Uncategorized, Understanding APC, Zometa|0 Comments